iNOS inhibitors (Berlex)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameiNOS inhibitors (Berlex)
Drug Alias Nameinflammation therapeutics (Berlex/Pharmacopeia)BBS-2ZK-809984PS-891169ZK-810000
ClassificationSmall molecules
Mechanisms of ActionNitric oxide synthase, inducible inhibitors
TargetsNitric oxide synthase, inducible
Therapy Area/IndicationsInflammationReperfusion InjuryMultiple Sclerosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmacopeia Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBerlex Laboratories IncPharmacopeia Llc
Active IndicationsN/A
Inactive IndicationsInflammationReperfusion InjuryMultiple Sclerosis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A